O'Day David G MD is categorized under Internal Medicine Doctors in Charleston, SC and active since 2008.
O'Day David G MD was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact David O'Day at the company’s single location by writing to 3531 Mary Ader Avenue # C, Charleston, South Carolina SC 29414 or by phoning (843) 856-5275. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | O'Day David G MD |
| Contact Person: | David O'Day |
| Address: | 3531 Mary Ader Avenue # C, Charleston, South Carolina 29414 |
| Phone Number: | (843) 856-5275 |
| Website Address: | charlestoncornea.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
O'Day David G MD was started in 2008 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact David O'Day for inquiries that concern O'Day David G MD by calling the company number (843) 856-5275, as your correspondence is most welcome. Additionally, the physical location of the single location of O'Day David G MD can be found at the coordinates 32.82094,-80.06502 as well as the street address 3531 Mary Ader Avenue # C in Charleston, South Carolina 29414.
For its online presence, you may visit O'Day David G MD’s website at charlestoncornea.com and engage with its social media outlets through on Twitter and on Facebook.